TP53 and endometrial cancer: Although this finding has not been clearly explained in BC, previous observations in endometrial cancer have found that the hypermethylation of the BIRC5 promoter blocks the binding of p53, a repressor of BIRC5 gene transcription, to its promoter region, thus increasing its expression [42,43].